ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE turns down rare skin disease implant
pharmatimes
December 21, 2017The National Institute for Health and Care Excellence has rejected Clinuvel UK’s afamelanotide for treating erythropoietic protoporphyria (EPP) in preliminary guidelines deeming it far too expensive for NHS use.
Pharma Sources Insight July 2025
